S06393 Summary:

BILL NOS06393
 
SAME ASSAME AS A03981
 
SPONSORREICHLIN-MELNICK
 
COSPNSRGAUGHRAN
 
MLTSPNSR
 
Amd 6816-a, Ed L
 
Relates to the substitution of brand name epinephrine auto-injectors with alternate epinephrine auto-injectors in certain cases.
Go to top    

S06393 Actions:

BILL NOS06393
 
04/26/2021REFERRED TO HIGHER EDUCATION
05/18/20211ST REPORT CAL.1137
05/20/20212ND REPORT CAL.
05/24/2021ADVANCED TO THIRD READING
06/02/2021PASSED SENATE
06/02/2021DELIVERED TO ASSEMBLY
06/02/2021referred to higher education
01/05/2022died in assembly
01/05/2022returned to senate
01/05/2022REFERRED TO HIGHER EDUCATION
02/15/20221ST REPORT CAL.511
02/16/20222ND REPORT CAL.
02/17/2022ADVANCED TO THIRD READING
03/03/2022PASSED SENATE
03/03/2022DELIVERED TO ASSEMBLY
03/03/2022referred to higher education
Go to top

S06393 Committee Votes:

Go to top

S06393 Floor Votes:

There are no votes for this bill in this legislative session.
Go to top

S06393 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                          6393
 
                               2021-2022 Regular Sessions
 
                    IN SENATE
 
                                     April 26, 2021
                                       ___________
 
        Introduced  by  Sen. REICHLIN-MELNICK -- read twice and ordered printed,
          and when printed to be committed to the Committee on Higher Education
 
        AN ACT to amend the education law, in relation to  the  substitution  of
          brand name epinephrine auto-injectors with alternate epinephrine auto-
          injectors for dispensation by pharmacists

          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:
 
     1    Section 1. Section 6816-a of the education law is amended by adding  a
     2  new subdivision 6 to read as follows:
     3    6.  (a)  Notwithstanding  subdivision two of this section or any other
     4  section of law to the contrary, when a patient  is  prescribed  a  brand
     5  name epinephrine auto-injector, a pharmacist may substitute an alternate
     6  epinephrine auto-injector containing the same active ingredients, dosage
     7  form  and  strength  as  the  brand  name product prescribed, ordered or
     8  demanded, regardless of whether the alternate epinephrine  auto-injector
     9  is  included in the latest list of interchangeable drug products for the
    10  prescribed epinephrine auto-injector device, provided that:
    11    (i) the prescriber does not indicate that  the  prescription  therefor
    12  shall  be  dispensed as written pursuant to paragraph (a) of subdivision
    13  six of section sixty-eight hundred ten of this article;
    14    (ii) the alternate epinephrine auto-injector available would reflect a
    15  lower unit cost to the purchaser;
    16    (iii) the pharmacist has advised the purchaser of the availability  of
    17  an  alternate epinephrine auto-injector and obtained consent to dispense
    18  the alternate epinephrine auto-injector; and
    19    (iv) the pharmacist has counseled the patient or person authorized  to
    20  act  on  the patient's behalf on the proper usage and operating features
    21  of the alternate epinephrine auto-injector.
    22    (b) For purposes of this subdivision "epinephrine auto-injector" shall
    23  have the same meaning as provided in paragraph (b) of subdivision one of
    24  section three thousand-c of the public health law.
    25    § 2. This act shall take effect immediately.
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD00933-01-1
Go to top